FDA Inspection 1203671 — Agilera Pharma AS
The FDA completed an inspection of Agilera Pharma AS on Mar 24, 2023 in Kjeller. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 24, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kjeller (Norway)